logo
episode-header-image
Nov 18
30m 39s

The Cohere story part two: the hard ques...

CBC

About this episode

This is the second of a two part series on Cohere. In part one, we looked at why Ottawa is betting $1.6 billion on the Canadian AI company – and why some critics are skeptical.


Today, we put those questions to Cohere’s co-founder, Nick Frosst. Does Canada need superintelligence to compete in the global AI race? Is Cohere’s AI truly sovereign if it runs on American chips? And when will the company turn a profit?


We also get into the bigger fights over AI: fears about job loss, the backlash against data centres, and a copyright lawsuit from news publishers alleging that Cohere used their content without permission.


Listen to part one of this two part series: https://link.mgln.ai/DHEn68

 

For transcripts of Front Burner, please visit: https://www.cbc.ca/radio/frontburner/transcripts 

Up next

Nov 20
Relax, it’s probably not a cyber attack
Over the past week, a whole bunch of major tech outages have happened — affecting Microsoft, Apple, major banks, the U.S. National Security Administration, and temporarily grounding all flights across the United States.While officials and companies have repeatedly insisted that t ... 
28m 1s
Nov 19
The priest with Carney’s ear on homelessness
Earlier this month, as part of the rollout of the federal budget, Prime Minister Mark Carney announced that with a near $30-billion investment, the federal government hopes to end homelessness in Canada in the next 10 years. While making that announcement in Winnipeg he quoted Re ... 
28m 22s

Recommended Episodes

Apr 2021
Halted: Johnson & Johnson & the Vaccination Timeline
After 6 people in nearly 7 million Johnson & Johnson vaccine recipients developed a rare type of blood clot, the FDA and CDC have recommended a pause on administering that vaccine in the United States. CNBC’s Meg Tirrell digests the news and what it means for the rest of the J&J ... 
27m 20s
Apr 2021
Coronavirus: How Scary Are the Variants?
UPDATE 4/13/21: Since this episode published, there has been some evidence linking the Johnson & Johnson coronavirus vaccine to rare blood clots. As of April 13, there were six cases in the U.S. out of more than 6.8 million doses, and one person had died. The CDC and FDA have rec ... 
33m 54s
Apr 2021
Are all viral vector vaccines a problem?
American health regulators have paused the use of the Johnson & Johnson coronavirus vaccine, following reports of rare blood clotting in six recipients. Like the AstraZeneca vaccine, Johnson & Johnson is what's known as a viral vector vaccine - where another virus is used like a ... 
11m 14s
Mar 2021
Could German researchers have found a link between Astra and blood clots?
Researchers in Germany say they've identified what could be behind the reports of blood clotting in people who have had the AstraZeneca coronavirus vaccine. The German team - in yet to be released pre-print research - say that the vaccine could in rare circumstances cause an auto ... 
11m 11s
Apr 2021
VACCINE FACTS: Watch This While You Can ...
The CDC announced it is pausing one of the vaccines due to "blood clots." Which is funny, since Facebook blocks any video that brings up "blood clots." What's up with that? And we know all the riots can blend together, but we'll have the latest on both Derek Chauvin and Daunte Wr ... 
1h 18m